Law Articles
To search for a particular term please use the following search box.
Law Topics
Click on a Topic to see available articles for that topic.
- Accidents
- Administrative Law
- Admiralty Law
- Articles
- Banking
- Bankruptcy Law
- Canon Law
- Case Law
- Civil Law
- Civil Rights
- Class Action Lawsuits
- Commercial Law
- Common Law
- Comparative Law
- Constitutional Law
- Consumer Law
- Contracts
- Corporate Law
- Courts
- Criminal Law
- Cyber Law
- Dispute Resolution
- Employment Law
- Equity
- Evidence
- Family Law
- Fiduciary Law
- General Practice
- Government
- Health Law
- Immigration Law
- Insurance Law
- Intellectual Property
- International Law
- Jurisprudence
- Labor Law
- Law and Economics
- Maritime Law
- Military Law
- Natural Law
- Personal Injury Law
- Philosophy of Law
- Property Law
- Public Law
- Real Estate Law
- Social Security
- Space Law
- Statutory Law
- Tax Law
- Traffic Law
- Trusts and Estates
- Water Law
Return to Law Dictionary Index
Vision Loss Reported in a Few Viagra Users
Source: Pfizer
Published: May 31, 2005
The Food and Drug Administration said last week it is examining rare reports of partial vision loss in some men taking impotence drugs Viagra (made by Pfizer) and Cialis (made by El Lilly & Co.).
Pfizer said outside of clinical trials, Viagra has been used by more than 23 million men worldwide over the past seven years and reports of visual field loss due to non-arteritic anterior ischemic optic neuropathy (NAION) are extremely rare.
�There is no evidence showing that NAION occurred more frequently in men taking Viagra than men of similar age and health who did not take Viagra,� Pfizer said in a statement.
NAION is the most common acute optic nerve disease in adults over age 50 and it shares a number of common risk factors with erectile dysfunction: age over 50, high blood pressure, high cholesterol, diabetes.
�Most of the reported cases in which NAION has occurred in men taking Viagra have involved patients with underlying anatomic or vascular risk factors associated with the development of NAION,� the drug maker said.
Pfizer said it is in discussions with the Food and Drug Administration to update the Viagra label to reflect these rare ocular occurrences.
Read Full Story at Pfizer